Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bedside AI Sepsis Detection System Can Cut Hospital Deaths by 20%

By HospiMedica International staff writers
Posted on 22 Jul 2022

Sepsis occurs when an infection triggers a chain reaction throughout the body. More...

Inflammation can lead to blood clots and leaking blood vessels, and ultimately can cause organ damage or organ failure. About 1.7 million adults develop sepsis every year in the US and more than 250,000 of them die. Sepsis is easy to miss because symptoms such as fever and confusion are common in other conditions. The faster it's caught, the better a patient's chances for survival. Now, patients are 20% less likely to die of sepsis because a new AI system catches the symptoms hours earlier than traditional methods

The AI system developed by researchers at Johns Hopkins University (Baltimore, MD, USA) scours medical records and clinical notes to identify patients at risk of life-threatening complications. The work could significantly cut patient mortality from one of the top causes of hospital deaths worldwide. The machine-learning system, named Targeted Real-Time Early Warning System, combines a patient's medical history with current symptoms and lab results to show clinicians when someone is at risk for sepsis and suggests treatment protocols, such as starting antibiotics. The AI tracks patients from when they arrive in the hospital through discharge, ensuring that critical information isn't overlooked even if staff changes or a patient moves to a different department.

In an extensive hospital study, more than 4,000 clinicians from five hospitals used the AI in treating 590,000 patients. The system also reviewed 173,931 previous patient cases. In 82% of sepsis cases, the AI was accurate nearly 40% of the time. Previous attempts to use electronic tools to detect sepsis caught less than half that many cases and were accurate 2% to 5% of the time. All sepsis cases are eventually caught, but with the current standard of care, the condition kills 30% of the people who develop it. In the most severe sepsis cases, where an hour delay is the difference between life and death, the AI detected it an average of nearly six hours earlier than traditional methods. The team has now adapted the technology to identify patients at risk for pressure injuries, commonly known as bed sores, and those at risk for sudden deterioration caused by bleeding, acute respiratory failure, and cardiac arrest.

"It is the first instance where AI is implemented at the bedside, used by thousands of providers, and where we're seeing lives saved," said Suchi Saria, founding research director of the Malone Center for Engineering in Healthcare at Johns Hopkins and lead author of the studies, which evaluated more than a half million patients over two years. "This is an extraordinary leap that will save thousands of sepsis patients annually. And the approach is now being applied to improve outcomes in other important problem areas beyond sepsis."

Related Links:
Johns Hopkins University 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.